Oversold

DCTH

Valuation28/ 100
Cash flow & growth52/ 100
Upside potential31/ 100
Risk potential57/ 100

DCTH's valuation is somewhat elevated, fundamentals are somewhat mixed and weaker than expected earnings are holding it back, though analyst coverage is limited.

Score change since last week

The score fell 7 points, mainly due to valuation and price changes. Price rose 0.9%, from $16.34 to $16.48. Reported EPS was unchanged, so the higher price reduced valuation support.

Valuation and price changes subtracted 6.7 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 1267.7× versus the full-history median of 170.5× shown in the valuation table, producing 27.9/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 27.8/100. The model applies a -10.6% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 425.2× (18-month half-life). The favorable scenario uses 952.1× PE and $0 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +35.8%, earnings -60.6%, operating margin -9 percentage points. Free cash flow is 18.3% of revenue. The business score is 51.6/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

The earnings calculation and the displayed scenario are different.

The earnings case uses $0.01 of EPS and a 952.1× PE, suggesting about $12.28 before the minimum is applied. Valuation history and outlook inform the PE.

The model applies a 15% minimum upside scenario, so the card shows +15%, or about $18.95. That adjusted price does not come from the EPS × PE calculation above.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.01 of EPS and a 786.3× PE, suggesting a share price of about $7.06 — 57% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

DCTH vs Historical averages

MetricCurrentAverageRelative
PE1,268x343x269% higher
PE percentile964994% higher
EPS$0.01-$11,991.99$11,992.01 higher
FCF$17.5M-$17.5M+$35M
Loading historical comparisons…

DCTH’s earnings are above their historical averages, while its earnings multiple is higher.

DCTH Forward outlook

MetricOutlook
Forward valuation--
Forward earningsTurning negative
Forward revenueStrong growth
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionTight

DCTH’s outlook is mixed, with weaker expected earnings weighing on the picture.

DCTH PE Valuation

Loading pe valuation table…

This table applies DCTH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

DCTH Earnings Per Share

Loading earnings per share…

This chart tracks DCTH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

DCTH Quarterly Revenue

Loading quarterly revenue…

This chart tracks DCTH's quarterly revenue over time and shows how sales are changing from year to year.

DCTH Free Cash Flow

Loading free cash flow…

This chart tracks DCTH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

DCTH Total Shares

Loading shares over time…

This chart tracks changes in DCTH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

DCTH Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

DCTH PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares DCTH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

DCTH Weekly Price

Loading weekly price…

This chart uses DCTH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

DCTH Weekly Moving Averages

Loading weekly moving averages…

This chart compares DCTH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

DCTH Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.